Key corporate developments this session: MicroPort NeuroTech (02172) has received approval for its NuWismen® Zhi™ liquid embolic agent to enter the NMPA innovation fast-track channel. Henlius (02696) has entered into a collaboration and licensing agreement with Amberstone for two T-cell engager products. Shougang Lanza (02553) has obtained the ISCC EU certification certificate.
Estun (02715) plans to acquire approximately 44.8601% of the shares in Estun Jiangsu Intelligent, raising its stake to around 95.0107%. Tuhu-W (09690) intends to acquire all shares of Conti Trade Australia Pty Ltd for A$278 million. Tiantu Capital (01973)'s subsidiary plans to subscribe for equity in Topos AI Infra Holdings and Topos AI Infra Investments, with a total commitment of US$25 million.
China Risun Group (01907) is set to inject 507 million yuan into Xiangfu New Energy to accelerate its capacity expansion. Central China Management (09982) plans to acquire a 25% stake in Lianheng Technology for HK$100 million, launching a new "agency construction plus AI technology" business model.
On the buyback front: HSBC Holdings (00005) spent HK$152 million on September 22 to repurchase 948,800 shares. Tencent Holdings (00700) used HK$100 million on September 23 to buy back 227,000 shares. Xiaomi Corporation-W (01810) repurchased 2.378 million shares for HK$62.3976 million on September 23. Baidu Group-W (09888) spent approximately HK$49.9958 million to repurchase 561,800 shares on the same day.
Operational results: Nine Dragons Paper (02689) posted annual results with shareholders' profit attributable to owners of 3.581 billion yuan, rising 102.62% year-on-year. Asia Resources Holdings (01104) reported annual results with shareholders' profit attributable to owners of HK$1.711 billion, surging 601.69% year-on-year.
Comments